Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medmont is an Australian private medical device company focused on ophthalmic and optometric diagnostics. The company designs, develops, manufactures, and supports eye-care instruments in-house, including corneal topographers, automated perimeters, imaging software, and visual acuity testing products. Its product portfolio includes the Medmont Meridia advanced topographer, E300 corneal topographer, M700 automated perimeter, DV2000 imaging software, AT20P acuity tester, and the Medmont Studio software environment. Medmont primarily serves ophthalmologists, optometrists, contact lens specialists, and researchers worldwide. The business appears to be a commercial-stage healthtech and diagnostic equipment manufacturer rather than a therapeutic biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medmont.